Back to search

Switzerland· 31890098

Mephameson 50 mg/3 ml, Injektionslösung

A dexamethasone product containing dexamethasonum, registered in Switzerland by Mepha Pharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC H02AB02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMephameson 50 mg/3 ml, Injektionslösu…ATCH02AB02REGISTER NO.31890098PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Dexamethasone is registered in 16 of 19 countries.

Countries holding a registration under ATC H02AB02 (dexamethasone), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Dexamethasone · ATC H02AB02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dexamethasone costs, country by country.

Normalised to the WHO defined daily dose (1.5 mg), so markets compare like for like.

  • Switzerland: $0.57 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Dexamethasone · price per daily dose (1.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.57
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
dexamethasonum
Manufacturer
Mepha Pharma AG
Country
Switzerland (CH)
ATC code
H02AB02
ATC class
Dexamethasone
Defined daily dose
1.5 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680318900983
    25 Amp 3 ml
    CHF 358.3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1091 interactions on record for dexamethasone.

Graded by severity as the source publishes them — 133 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dexamethasone · interactions on record

1091 records

  • 133 severe
  • 525 moderate
  • 62 minor
  • 350 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • DesirudinB01AE01severe
  • VoxelotorB06AX03severe
  • AmiodaroneC01BD01severe

21 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dexamethasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexamethasone products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Dexamethason Hcs, Dexamethason Kalceks
  • Belgium · Darazon, Dexalis
  • Bulgaria · Dexanova, Дeксаметазон Крка
  • Cyprus · Axium-Opto, Decadron
  • Czechia · Dexamed, Dexamethasone Fmk
  • Germany · Dexa, Dexa Edo
  • Denmark · Axiumopto, Dexacur
  • Estonia · Caltrixan, Dexamethason Krka
  • Spain · Amexxine, Dexafree
  • Finland · Axiumopto, Dexacur
  • France · Aflavis, Dectancyl
  • United Kingdom (Northern Ireland) · Dexafree, Dexamethason Glenmark Pharmaceuticals Europe
  • Greece · Amelinor, Axium
  • Croatia · Darazur, Deksametazon Kalceks
  • Hungary · Darazur, Dexamethasone Kalceks
  • Ireland · Dexafree, Dexamethasone Activase Pharmaceuticals
  • Iceland · Dexametason Abcur, Dexamethason Krka
  • Italy · Amexzur, Cortmuper
  • Liechtenstein · Neofordex, Ozurdex
  • Lithuania · Dexamethason Krka, Dexamethasone Kalceks
  • Luxembourg · Dexalis, Dexamethasone Kalceks
  • Latvia · Dexamethason Krka, Dexamethasone Kalceks
  • Malta · Axium-Opto, Decadron
  • Netherlands · Axium-Opto, Dexamethason
  • Norway · Dexacur, Dexametason Abcur
  • Poland · Covexan, Darazur
  • Portugal · Amexzur, Decadron
  • Romania · Dexametazonă Fosfat Krka, Dexametazona Krka
  • Sweden · Axiumopto, Baxil
  • Slovenia · Deksametazon Krka, Deksametazon Medochemie
  • Slovakia · Amexxine, Dexametazón Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f80a9c44-b945-49a6-aa43-8ba61edeff22
GET /v1/drugs/f80a9c44-b945-49a6-aa43-8ba61edeff22?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "dexamethasoni natrii phosphas 50 mg",
  "valid_from": "2020-04-01",
  "limitations": null,
  "galenic_form": "Inj Lös 50 mg/3ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2020-04-01",
  "self_retention_pct": 10
}

See everything about dexamethasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.